{"SPADE_N_06319": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_06319", "Peptide Name": "MIP(M11A)", "Source": "E3 ubiquitin-protein ligase", "Family": "", "Gene": "Not found", "Sequence": "PRFWEYWLRLAE", "Sequence Length": 12, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:-- (IC50 for MDM2=0.4 ÂµM)", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "MDM2", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C82H112N20O18", "Mass": 1665.89, "PI": 6.7, "Net Charge": 0, "Hydrophobicity": -0.71, "Half Life": "Mammalian:>20 hourYeast:>20 hourE.coli:/", "Comments": "Inhibits MDM2-p53 Interaction", "Literature": [{"Title": "mRNA display selection of an optimized MDM2-binding peptide that potently inhibits MDM2-p53 interaction", "Pubmed ID": "21423613", "Reference": "PLoS One. 2011 Mar 15;6(3)e17898.", "Author": "Shiheido H, Takashima H, Doi N, Yanagawa H.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=21423613"}], "Frequent Amino Acids": "ELR", "Absent Amino Acids": "CDGHIKMNOQSTUV", "Basic Residues": 2, "Acidic Residues": 2, "Hydrophobic Residues": 8, "Polar Residues": 4, "Positive Residues": 2, "Negative Residues": 2, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_01899", "Similarity": 1.0, "Sequence": "RLAEIVVIRVAR"}, {"SPADE_ID": "SPADE_N_06320", "Similarity": 0.9166666666666666, "Sequence": "PRFWEYWLRLME"}, {"SPADE_ID": "SPADE_N_06315", "Similarity": 0.8333333333333334, "Sequence": "PRFWEAWLRLME"}]}}}